First Time Loading...

Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 14.89 USD 0.95%
Updated: May 10, 2024

Verona Pharma PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Net Income (Common) Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Net Income (Common)
-$54.4m
CAGR 3-Years
6%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Net Income (Common)
£4.5B
CAGR 3-Years
-5%
CAGR 5-Years
3%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Net Income (Common)
$6.3B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
12%
Indivior PLC
LSE:INDV
Net Income (Common)
$5m
CAGR 3-Years
-63%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Net Income (Common)
$190m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Net Income (Common)
-£27.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Verona Pharma PLC's Net Income (Common)?
Net Income (Common)
-54.4m USD

Based on the financial report for Dec 31, 2023, Verona Pharma PLC's Net Income (Common) amounts to -54.4m USD.

What is Verona Pharma PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-15%

Over the last year, the Net Income (Common) growth was 21%. The average annual Net Income (Common) growth rates for Verona Pharma PLC have been 6% over the past three years , -15% over the past five years .